MEDSHAPE, INC.
Atlanta, US
MedShape develops foot and ankle surgical implants and instruments, including total ankle replacement systems, plating, screws, staples, biologics, and NiTiNOL-based dynamic compression devices such as the DynaNail family. Its products are designed for surgeons performing fusion, fracture, osteotomy, bunion, hammertoe, and minimally invasive foot and ankle procedures.
BiotechHealthtechMedical Devices
Founders & leadership
NN
Niles NoblittNamed on SEC filing
PF
Paul F. HillsNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$700K disclosed across 1 round · 2014
▶$700KraisedAug 2014 · 2 investors · BiotechnologyRule 506(b)
▶$700KraisedAug 2014 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Niles NoblittDirector
- Paul F. HillsDirector
- Offering amount
- $4M
- Amount sold
- $700K
- Minimum investment
- $100K
- First sale
- Jul 2014
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 12 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $191K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $149.5K |
| National Science Foundation | Phase I | 2013 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2012 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2011 | $920.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2009 | $839.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2009 | $159.1K |
| National Science Foundation | Phase II | 2008 | $499.8K |
| National Science Foundation | Phase I | 2008 | $99.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2008 | $97.5K |
| National Science Foundation | Phase I | 2007 | $99.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does MEDSHAPE, INC. do?
- MedShape develops foot and ankle surgical implants and instruments, including total ankle replacement systems, plating, screws, staples, biologics, and NiTiNOL-based dynamic compression devices such as the DynaNail family. Its products are designed for surgeons performing fusion, fracture, osteotomy, bunion, hammertoe, and minimally invasive foot and ankle procedures.
- How much funding has MEDSHAPE, INC. raised?
- MEDSHAPE, INC. has disclosed $700K raised across 1 round.
- Where is MEDSHAPE, INC. headquartered?
- MEDSHAPE, INC. is headquartered in Atlanta, US.